Ignalis 50 Tablet

Ignalis 50 is prescribed as an adjunct to diet and exercise to improve glycemic parameters in adult patients inadequately controlled on lifestyle modifications alone or in combination with other antidiabetic agents such as metformin, sulfonylureas, or insulin. The recommended dose is 50 mg once daily, with or without food. Dose adjustments may be necessary in patients with renal impairment.

Common adverse effects include nasopharyngitis, headache, and upper respiratory tract infections, while hypoglycemia risk increases when combined with sulfonylureas or insulin. Ignalis 50 should be used cautiously in patients with a history of pancreatitis. Regular monitoring of blood glucose levels, renal function, and potential side effects is advised during therapy. This medication should be prescribed under medical supervision, with patient adherence to lifestyle modifications emphasized for optimal therapeutic outcomes.